Cassava Sciences Shares Are Trading Higher Today: What You Need To Know
Portfolio Pulse from Vaishali Prayag
Cassava Sciences, Inc. (NASDAQ:SAVA) saw its stock price surge by 24.4% to $29.21, driven by rising short interest and an upcoming conference call. The company has a high short percent of float at 35.89%, and it would take traders 4.75 days to cover their short positions. Cassava plans to extend its open-label extension trials for simufilam by up to 36 months.
August 02, 2024 | 7:52 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cassava Sciences shares surged by 24.4% to $29.21, driven by rising short interest and anticipation of an upcoming conference call. The company plans to extend its simufilam trials by up to 36 months.
The significant rise in stock price is attributed to increased short interest and the anticipation of a conference call, which suggests positive investor sentiment. The extension of simufilam trials is also a positive development, indicating ongoing progress in their drug pipeline.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100